• Budd-Chiari syndrome
  • Cytochrome P450 21A2 (CYP21A2) Genotyping
  • FOXL2 Gene Mutation Analysis
  • Hereditary diffuse gastric cancer
  • COL1A1/COL1A2 Genes Variations Analysis
  • Congenital hemolytic anemia
  • Seizure
  • Products of Conception, Ploidy by Flow Cytometry
  • Amyotrophic lateral sclerosis
  • Primary pulmonary hypertension
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Urine Drug Testing Adulteration Assay
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Urine Drug Testing Adulteration Assay
Medical Test

Methodology
Access to Urine Drug Testing Adulteration Assay is restricted.